Tsumura & Co.:企業の戦略・SWOT・財務分析

◆英語タイトル:Tsumura & Co. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4843
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Tsumura & Co. – Strategy, SWOT and Corporate Finance Report
Summary

Tsumura & Co. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Tsumura & Co. (Tsumura or ‘the company’) is involved in the manufacturing and sale of pharmaceutical products, including prescription Kampo products. The company operates in Japan, China, South Korea and other countries. Tsumura offers several products such asprescription Kampo products, over-the-counter (OTC) formulations, other pharmaceuticals, Chinese crude drug pieces and other products. The company’s products find application in treating various disease such as neurosis, abdominal pain and flatulence, insomnia, gastritis, anorexia, maldigestion, bronchitis, cough, oversensitivity to cold, bronchial asthma, menstrual irregularity, leg pain, climacteric disturbance, dysuria, low back pain, swelling (edema), acute, numbness and others. It is headquartered in Tokyo, Japan.

Scope

- Detailed information on Tsumura & Co. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Tsumura & Co. in the form of a SWOT analysis
- An in-depth view of the business model of Tsumura & Co. including a breakdown and examination of key business segments
- Intelligence on Tsumura & Co.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Tsumura & Co., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Tsumura & Co. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Tsumura & Co. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Tsumura & Co.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Tsumura & Co.: Company Overview
Tsumura & Co.: Overview and Key Facts
Tsumura & Co.: Overview
Tsumura & Co.: Key Facts
Tsumura & Co.: Key Employees
Tsumura & Co.: Major Products and Services
Tsumura & Co.: Company History
Tsumura & Co.: Management Statement
Tsumura & Co.: Locations and Subsidiaries
Tsumura & Co.: Key Competitors
Tsumura & Co.: Company Analysis
Tsumura & Co.: Business Description
Tsumura & Co.: SWOT Analysis
Tsumura & Co.: SWOT Overview
Tsumura & Co.: Strengths
Tsumura & Co.: Weaknesses
Tsumura & Co.: Opportunities
Tsumura & Co.: Threats
Tsumura & Co.: Corporate Financial Deals Activity
Tsumura & Co.: Financial Deals Overview
Tsumura & Co.: Targets and Partners
Tsumura & Co.: Top Deals 2016 – 2020YTD*
Tsumura & Co.: Advisors
Tsumura & Co.: Top Financial Advisors
Tsumura & Co.: Capital Raising
Tsumura & Co.: Partnership
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Tsumura & Co.: Key Facts
Table 2: Tsumura & Co.: Key Employees
Table 3: Tsumura & Co.: Company History
Table 4: Tsumura & Co.: Locations and Subsidiaries
Table 5: Tsumura & Co.: Key Competitors
Table 6: Tsumura & Co.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: Tsumura & Co.: Targets and Partners
Table 8: Tsumura & Co.: Top Deals 2016 - 2020YTD*
Table 9: Tsumura & Co.: Financial Advisor Ranking by Value (US$m)
Table 10: Tsumura & Co.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 11: Tsumura & Co.: Capital Raising by Deal Type (2016 - YTD*2020)
Table 12: Tsumura & Co.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 13: Tsumura & Co.: Partnership Trend by Deal Type (2016 - YTD*2020)

★海外企業調査レポート[Tsumura & Co.:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mateon Therapeutics Inc (MATN):企業の財務・戦略的SWOT分析
    Summary Mateon Therapeutics Inc (Mateon), formerly OXiGENE Inc is a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications. The company develops therapeutics to treat cancer and eye diseases; and anti-vascular drugs such as vascular disrupting age …
  • Opsona Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Opsona Therapeutics Ltd (Opsona) is a biopharmaceutical company that conducts research, develops and commercializes new treatment for the autoimmune and inflammatory diseases and cancers. The company's OPN-305 is a humanized antibody used to reduce pro-inflammatory cytokine production that i …
  • Immunomic Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Immunomic Therapeutics Inc (ITI) is a biotechnology company that specializes in developing vaccines based on the patented lysosomal associated membrane protein or lamp technology. The company's pipeline product portfolio drugs for allergy vaccine therapy and oncology immunotherapy. It develo …
  • Grupo Televisa, S.A.B. (TLEVISACPO):企業の財務・戦略的SWOT分析
    Grupo Televisa, S.A.B. (TLEVISACPO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Kuwait Petroleum Corp:企業の戦略的SWOT分析
    Kuwait Petroleum Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Dis-Chem Pharmacies Limited (DCP):企業の財務・戦略的SWOT分析
    Dis-Chem Pharmacies Limited (DCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Tivoli A/S
    Tivoli A/S - Strategy, SWOT and Corporate Finance Report Summary Tivoli A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Resverlogix Corp (RVX)-製薬・医療分野:企業M&A・提携分析
    Summary Resverlogix Corp (Resverlogix) is an epigenetics company that develops small molecule therapeutics for Bromodomain and ExtraTerminal Domain (BET) inhibition. The company provides lead product such as RVX-208 (apabetalone), is a BET inhibitor under phase III clinical trial. Its RVX-208 is bei …
  • Mercy:企業の戦略的SWOT分析
    Mercy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This u …
  • Bureau Veritas SA (BVI):電力:M&Aディール及び事業提携情報
    Summary Bureau Veritas SA (Bureau Veritas) is a provider of testing, inspection and certification services. The company offers asset management, certification, consulting, inspection and audits, testing and analysis, and training. It serves aeronautics, agriculture, automotive, construction and real …
  • Domino’s Pizza, Inc.:企業の戦略・SWOT・財務分析
    Domino's Pizza, Inc. - Strategy, SWOT and Corporate Finance Report Summary Domino's Pizza, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • LivaNova PLC (LIVN):医療機器:M&Aディール及び事業提携情報
    Summary LivaNova PLC (LivaNova) is a medical technology company that offers medical devices for cardiac surgery and neuromodulation. The company’s neuromodulation provides vagus nerve stimulation therapy system, an implantable device for the people affected by treatment-resistant epilepsy, depressio …
  • PhaseBio Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PhaseBio Pharmaceuticals Inc (PhaseBio) is a clinical-stage biopharmaceutical company that develops biotherapeutics for the treatment of orphan diseases and cardiopulmonary indications. The company offers ELP biopolymer technology, which includes PE0139 and PB1023 pipeline products. PhaseBio …
  • Guangzhou R&F Properties Co Ltd:企業の戦略・SWOT・財務情報
    Guangzhou R&F Properties Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Guangzhou R&F Properties Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Spectrum Brands Holdings, Inc.:企業の戦略・SWOT・財務分析
    Spectrum Brands Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Spectrum Brands Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Lipocine Inc (LPCN):企業の財務・戦略的SWOT分析
    Summary Lipocine Inc (Lipocine) is a pharmaceutical company that develops and commercializes treatment for men's and women's health. The company’s pipeline products for men’s health include LPCN 1111 and LPCN 1021; and for women’s health include LPCN 1107. Its LPCN 1111 is an oral testosterone produ …
  • Condor Petroleum Inc (CPI):石油・ガス:M&Aディール及び事業提携情報
    Summary Condor Petroleum Inc. (Condor) is an independent upstream oil and gas company. The company through its subsidiaries, acquires, explores, produces and markets oil and gas. It has operational presence in Kazakhstan and Turkey. The company operates on the Pre-Caspian basin, a prolific region th …
  • Transport for London:企業の戦略的SWOT分析
    Transport for London - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Celsia SA ESP (CELSIA):電力:M&Aディール及び事業提携情報
    Summary Celsia SA ESP (Celsia), formerly Compania Colombiana de Inversiones SA ESP, a subsidiary of Grupo Argos SA, is an energy company that generates, transmits, distributes, and sells electricity. The company’s product categories include home line, solar energy, backup energy, thermal network, ef …
  • Kungsleden AB:企業のM&A・事業提携・投資動向
    Kungsleden AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kungsleden AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆